Skip to main content
. 2022 Oct 21;101(42):e31136. doi: 10.1097/MD.0000000000031136

Table 2.

Score of Alzheimer’s disease (AD) preventive behaviors related to drugs according to the intention and prior experience.

Score range Total (n = 147) AD-preventive behaviors related to medicines
Intention to take AD-preventive medicines Experience of taking Gingko biloba or similar medicines
Yes (n = 139) No (n = 8) P value Yes (n = 68) No (n = 79) P value
HBM variables
Total score 30-150 106.6 (11.0) 107.2 (10.7) 97.1 (12.0) .012 108.7 (10.8) 104.8 (10.8) .029
Perceived susceptibility 4-20 12.9 (3.6) 13.0 (3.5) 10.6 (3.7) .068 13.7 (3.5) 12.2 (3.5) .010
Perceived severity 4-20 15.7 (2.8) 15.7 (2.7) 14.3 (3.3) .142 16.0 (2.8) 15.3 (2.8) .143
Perceived benefits 4-20 16.5 (2.4) 16.5 (2.4) 15.5 (2.5) .247 16.8 (2.4) 16.2 (2.5) .172
Perceived barriers 11-55 34.9 (6.4) 34.9(6.5) 34.6 (4.2) .914 34.6 (6.6) 35.1 (6.3) .630
Self-efficacy 7-35 26.8 (4.5) 27.0 (4.4) 22.1 (4.8) .003 27.7 (4.4) 26.0 (4.5) .020
Cue to action 5-25 12.7 (3.4) 12.8 (3.5) 10.8 (2.0) .096 13.8 (3.7) 11.8 (3.0) .000
Non-HBM variables
Knowledge of dementia 0-12 9.7 (1.3) 9.7 (1.2) 8.13 (1.4) .001 9.7 (1.2) 9.6 (1.3) .518

Values are presented as mean (SD).

t test

AD = Alzheimer’s disease, HBM = health belief model, MCI = mild cognitive impairment, SD = standard deviation.